Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 30.70
-0.50 (-1.60%)
Jun 18, 2026, 1:30 PM CST
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 3.83 billion as of June 18, 2026. Its market cap has decreased by -47.61% in one year.
Market Cap
3.83B
Enterprise Value
3.82B
Revenue
682.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.70
Market Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 3.83B, an increase of 755.61%. That is a compound annual growth rate of 11.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.83B | -14.25% |
| Dec 31, 2025 | 4.46B | -43.03% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 5.58B |
| LIWANLI Innovation | 5.47B |
| SCI Pharmtech | 5.18B |
| Orient EuroPharma | 3.90B |
| Yoda Pharmaceuticals | 3.27B |
| Tien Liang BioTech | 3.26B |
| Maywufa Company | 2.90B |
| Merdury Biopharmaceutical | 2.74B |